Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease (original) (raw)
Abstract
The messenger RNAs for the angiogenic acidic and basic fibroblast growth factors are expressed at a significantly higher level in samples of human benign neoplastic and hyperplastic tissue than in samples from breast cancers. However, approximately one in four malignant breast cancer samples contain basic fibroblast growth factor mRNA at the same level as in the benign lesions when basic fibroblast growth factor mRNA levels are corrected with respect to levels of expression of glyceraldehyde-3-phosphate dehydrogenase mRNA. A similar proportion of human malignant breast cancer cell lines express a high level of basic fibroblast growth factor mRNA. The results suggest that some malignant breast cancers and their constitutive carcinoma cells express abundant levels of basic fibroblast growth factor mRNA. The resultant production of basic fibroblast growth factor by breast cancer cells within some tumours may contribute to their development.
Access through your institution
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Construction and analysis of pseudogene-related ceRNA network in breast cancer
Article Open access 10 December 2023
Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer
Article Open access 17 May 2024
Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis
Article Open access 04 December 2024
Author information
Authors and Affiliations
- Department of Biochemistry, University of Liverpool, UK
SY Anandappa
Authors
- SY Anandappa
View author publications
Search author on:PubMed Google Scholar - JHR Winstanley
View author publications
Search author on:PubMed Google Scholar - S Leinster
View author publications
Search author on:PubMed Google Scholar - B Green
View author publications
Search author on:PubMed Google Scholar - PS Rudland
View author publications
Search author on:PubMed Google Scholar - R Barraclough
View author publications
Search author on:PubMed Google Scholar
Rights and permissions
About this article
Cite this article
Anandappa, S., Winstanley, J., Leinster, S. et al. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease.Br J Cancer 69, 772–776 (1994). https://doi.org/10.1038/bjc.1994.146
- Issue date: 01 April 1994
- DOI: https://doi.org/10.1038/bjc.1994.146
This article is cited by
Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles
- Jitendra Kanodia
- Diana Chai
- Birgit Schoeberl
Cell Communication and Signaling (2014)
Trace elements as tumor biomarkers and prognostic factors in breast cancer: a study through energy dispersive x-ray fluorescence
- Marina P Silva
- Danilo F Soave
- Martin E Poletti
BMC Research Notes (2012)
Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients
- H E Innes
- D Liu
- P S Rudland
British Journal of Cancer (2006)
The C-terminal region of S100A4 is important for its metastasis-inducing properties
- Shu Zhang
- Guozheng Wang
- Roger Barraclough
Oncogene (2005)
Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines
- V E Moye
- R Barraclough
- P S Rudland
British Journal of Cancer (2004)